All In Biotech

Drug Trial Radar · NCT05857267

Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety

Phase IV, Multicenter, Double-blind, Randomized, Controlled, Parallel-group, Trial to Evaluate the Efficacy and Safety of Dozolamide 2%/Timolol 0,5% PF vs Dorzolamide 2%/Timolol 0,5% BAK-preserved in OAG or OH

Last checked: Nov 20, 2026Latest source record: Nov 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

84

Actual

Start

Mar 7, 2023

Primary completion

Nov 4, 2024

Study completion Nov 4, 2024

Sponsor

Lead sponsor
Laboratorios PoenIndustry
Sponsor type
Industry
First posted
May 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate the tolerability of the new formulation of Dorzolamide+Timolol preservative free developed in OSD Aptar Pharma multidose system in comparison with Dorzolamide +Timolol BAK preserved ophthalmic formulation.

Conditions

  • Glaucoma, Open-Angle
  • Ocular Hypertension

Interventions

  • Dorzolamide / Timolol Ophthalmic SolutionDrug

    Dorzolamide-timolol fixed combination in a preservative-free multidose device

  • dorzolamide/timololDrug

    Dorzolamide-timolol BAK-preserved fixed combination

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular Surface Disease SymptomsTime frame: Change from baseline in OSDI score at 24 weeks

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Consultorios de Oftalmología

    Buenos Aires, Argentina

  • Clínica de Ojos Dr. Nano

    Olivos, Buenos Aires, Argentina

  • Consultorio Dr. Peyret

    Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

  • Gonella Oftalmólogos

    Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

  • Centro Diagnóstico Dr. Gentile

    Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

  • Centro oftalmológico Dr. Casiraghi & asociados

    Ciudad Autónoma de Buenos Aire, Buenos Aires F.D., Argentina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.